3374
H.V. Huynh, R. Jothibasu / Journal of Organometallic Chemistry 696 (2011) 3369e3375
Table 4
(300 MHz, DMSO-d6): d 7.31 (s, 2H, CH), 7.27 (s, 2H, CH), 4.84 (m, 2H,
Selected X-ray crystallographic data for complexes 6 and 8.
NCHH), 4.34 (m, 2H, NCHH), 3.91 (s, 6H, CH3), 2.33 (m, 1H, CHH), 1.73
(m,1H, NCHH).13C{1H}NMR(75.47MHz,DMSO-d6): 123.0 (CH),122.8
(CH), 51.3 (NCH2), 37.5 (CH3), 30.6 (CH2). The carbene signal of 3 could
not be detected due to poor solubility. MS (ESI): m/z ¼ 390 [MeBr]þ.
6∙0.5Et2O
8∙0.5CH3CN
Formula
C21H25Br2N4O0.5Pd
C28H27.5Br2N4.5Pd
693.27
Formula weight
Colour
607.67
Yellow
Colourless
223(2)
0.54 ꢁ 0.12 ꢁ 0.06
Monoclinic
C2/c
32.294(2)
9.1189(6)
20.7260(14)
90
116.8280(10)
90
5446.5(6)
8
1.691
2.01 to 27.50
18981
Temperature (K)
Crystal size (mm)
Crystal system
Space group
a (Å)
223(2)
4.1.7. Dibromido-(1,10-dimethyl-3,30-ethylenedibenzimidazolin-
2,20-diylidene)palladium(II) (5)
Complex 5 was synthesized in analogy to compound 2 from
E$2HBr (226 mg, 0.5 mmol) and Pd(OAc)2 (113 mg, 0.5 mmol) and
isolated as a yellow solid (131 mg, 0.24 mmol, 47%). 1H NMR
0.40 ꢁ 0.30 ꢁ 0.06
Orthorhombic
Pmn21
17.2475(9)
8.2837(4)
15.1503(8)
90
b (Å)
c (Å)
(300 MHz, DMSO-d6): d 7.69 (m, 4H, Ar-H), 7.39 (m, 4H, Ar-H), 5.62
a
b
g
(ꢀ)
(ꢀ)
(ꢀ)
(br s, 2H, CHH), 5.07 (br s, 2H, CHH), 4.14 (s, 6H, CH3). The 13C NMR
spectrum of 5 could not be obtained due to poor solubility. MS
(ESI): m/z ¼ 476 [MeBr]þ.
90
90
V (Å3)
Z
2164.57(19)
4
1.865
1.79 to 27.49
14782
Dc (g cmꢂ3
q
)
4.1.8. Dibromido-(1,10-dimethyl-3,30-propylenedibenzimidazolin-
2,20-diylidene)palladium(II) (6)
Complex 6 was synthesized in analogy to compound 2 from
F$2HBr (233 mg, 0.5 mmol) and Pd(OAc)2 (113 mg, 0.5 mmol) and
isolated as a yellow solid (246 mg, 0.43 mmol, 86%). 1H NMR
range (ꢀ)
Unique data
Final R indices [I > 2
s
(I)]
R1 ¼ 0.0384,
R1 ¼ 0.0505,
wR2 ¼ 0.1029
wR2 ¼ 0.1123
(300 MHz, DMSO-d6): d 7.71 (m, 2H, Ar-H), 7.60 (m, 2H, Ar-H), 7.31 (m,
4H, Ar-H), 5.23 (m, 2H, NCHH), 4.90 (m, 2H, NCHH), 4.23 (s, 6H, CH3),
2.73(m,1H, CHH), 2.27(m,1H, CHH). The13CNMRspectrumof6could
not be obtained due to poor solubility. MS (ESI): m/z ¼ 491 [MeBr]þ.
3.0 mmol for dihalides), anhydrous sodium acetate (1.5 mmol),
catalyst (0.005 mmol), and [Bu4N]Br (1.5 mmol). To the mixture was
then added DMF (3 mL). The reaction mixture was vigorously stirred
at 150 ꢀC. After the desired reaction time, the solution was allowed
to cool. Dichloromethane (10 mL) was added to the reaction
mixture, and the organic phase was washed with water (6 ꢁ 5 mL)
and dried over MgSO4. The solvent was removed by evaporation to
give a crude product, which was analyzed by 1H NMR spectroscopy.
4.1.9. Pd(II) hetero-dicarbene complex (7)
Pd(OAc)2 (0.15 g, 0.67 mmol) was added to a DMSO solution of
compound I$2HBr (0.333 g, 0.8 mmol). The orange solution was
stirred for 12 h at 90 ꢀC. The reaction mixture was filtered over
Celite, and the solvent of the filtrate was removed by vacuum
distillation. The resulting residue was washed with water and
subsequently with ethanol. Upon drying the residue under vacuum,
complex 7 (0.275 g, 0.53 mmol, 79%) was isolated as a pale yellow
4.3. X-ray diffraction studies
Suitable single crystals were mounted on glass fibres. X-ray data
were collected with a Bruker AXS SMARTAPEX diffractometer, using
Mo Ka radiation, with the SMART suite of programs [22]. Data was
processed and corrected for Lorentz and polarization effects with
SAINT [23], and for absorption effect with SADABS [24]. Structural
solution and refinement were carried out with the SHELXTL suite of
programs [25]. The structure was solved by direct methods to locate
the heavy atoms, followed by difference maps for the light, non-
hydrogen atoms. All hydrogen atoms were put at calculated posi-
tions. All non-hydrogen atoms were generally given anisotropic
displacement parameters in the final model. A summary of the most
important crystallographic data is given in Table 4.
powder. 1H NMR (300 MHz, DMSO-d6):
d 7.74 (m, 1 H, Ar-H), 7.62
(m, 1 H, Ar-H), 7.37e7.25 (m, 4 H, Ar-H), 5.16 (m, 1 H, NCHH), 4.89
(m, 2 H, NCHH), 4.41 (m, 1 H, NCHH), 4.20 (s, 3 H, NbimiCH3), 3.94 (s,
3 H, NimiCH3), 2.44 (m, 1 H, CHH), 1.82 (m, 1 H, CHH). 13C{1H} NMR
(75.47 MHz, DMSO-d6): 174.3 (NCbimiN),159.6 (NCimiN),133.9,133.4,
123.4, 123.3, 123.1, 111.0, 110.4 (Ar-C), 51.6 (NbimiCH2), 48.4
(NimiCH2), 37.6 (NbimiCH3), 35.0 (NimiCH3), 30.2 (CH2). MS (ESI): m/z
482 [MeBr þ CH3CN]þ.
4.1.10. Pd(II) hetero-dicarbene complex (8)
A mixture of salt J$2HBr (0.341 g, 0.6 mmol) and Pd(OAc)2
(0.112 g, 0.5 mmol) in DMSO (8 mL) was stirred at 85 ꢀC for 12 h. The
reaction mixture was filtered over Celite and the solvent from the
filtrate was removed by vacuum distillation. The resulting residue
was washed with water and ethanol. Upon drying under reduced
pressure, complex 2 (0.289 g, 0.43 mmol, 86%) was obtained as an
Acknowledgements
The authors thank the National University of Singapore for
financial support (Grant No. R 143-000-407-112) and especially Ms
Geok Kheng Tan and Prof. Lip Lin Koh for determining the X-ray
molecular structures.
off-whitepowder.1HNMR (500MHz, DMSO-d6):
d 7.77(d,1 H, Ar-H),
7.37e7.30 (br m, 8 H, Ar-H), 7.18 (m, 5 H, Ar-H), 6.97 (d, 1 H, Ar-H),
6.91 (s, 1 H, Ar-H), 6.25 (d, 1 H, NCHHPh), 5.88 (d, 1 H, NCHHPh),
5.34 (t, 1 H, NCHH), 5.25 (d, 1 H, NCHHPh), 5.05 (t, 1 H, NCHH), 4.93
(dd,1 H, NCHH), 4.70 (d,1 H, NCHHPh), 4.48 (dd,1 H, NCH2), 2.54 (m,
1 H, CHH), 2.00 (m,1 H, CHH).13C{1H} NMR (125.77 MHz, DMSO-d6):
175.0 (NCbimiN),160.2 (NCimiN),136.0,135.1,133.9,132.8,128.5,128.4,
128.0,127.9,127.8,127.3,124.3,123.5,123.3,121.3,111.8,110.9 (Ar-C),
52.8 (NbimiCH2Ph), 51.8 (NbimiCH2), 51.6 (NimiCH2Ph), 48.6 (NimiCH2),
30.1 (CH2). MS (ESI): m/z ¼ 593 [MeBr]þ.
Appendix A. Supplementary material
CCDC 825978 (for 6∙0.5Et2O) and 825979 (for 8∙0.5CH3CN);
contains the supplementary crystallographic data for this paper.
These data can be obtained free of charge from The Cambridge
4.2. General procedure for the MizorokieHeck reaction
Supplementary data
In a typical run, a test tube was charged with a mixture of aryl
halide or dihalide (1.0 mmol), tert-butyl acrylate (1.5 mmol or
Supplementary data associated with this article can be found in